Exercise intolerance in patients with chronic heart failure. (Q40457694)

20 September 2017

1 reference

title

Exercise intolerance in patients with chronic heart failure. (English)

1 reference

20 September 2017

0 references

chronic heart failure

1 reference

Sullivan MJ

1

1 reference

PubMed ID

7631018

20 September 2017

Hawthorne MH

series ordinal

2

1 reference

20 September 2017

1 July 1995

1 reference

Progress in Cardiovascular Diseases

20 September 2017

1 reference

20 September 2017

38

1 reference

20 September 2017

1

1 reference

20 September 2017

1-22

1 reference

Epidemiology of congestive heart failure

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise capacity in patients with severe left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Determinants of variable exercise performance among patients with severe left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Usefulness of self-efficacy in predicting overexertion during programmed exercise in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The ventilatory threshold: quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure. The need for a preliminary test

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Reproducibility of cardiopulmonary exercise testing in men following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Cardiac rehabilitation for heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise testing in cardiac rehabilitation. Role in prescribing exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

DETECTING THE THRESHOLD OF ANAEROBIC METABOLISM IN CARDIAC PATIENTS DURING EXERCISE

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Predictors of mortality in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Twelve-minute walking test for assessing disability in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Two-, six-, and 12-minute walking tests in respiratory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Assessment of respiratory function in patients with chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of encouragement on walking test performance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The relationship of symptoms to performance in paced patients with breathlessness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The prognostic value of exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Mortality in heart failure: clinical variables of prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Prognosis of congestive heart failure and predictors of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Prognosis in patients with low left ventricular ejection fraction after myocardial infarction. Importance of exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dyspnea: physiological and pathophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise hyperventilation in patients with McArdle's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The sensation of breathlessness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Diaphragmatic fatigue in man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Mechanism of stimulation of type J pulmonary receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Respiratory changes during exercise in patients with pulmonary venous hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Factors determining symptoms in heart failure: comparison of fast and slow exercise tests

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Ventilation and gas exchange during exercise in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise intolerance in patients with chronic left heart failure: relation to oxygen transport and ventilatory abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of physical training on exercise-induced hyperkalemia in chronic heart failure. Relation with ventilation and catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dynamic exercise in man as influenced by experimental restriction of blood flow in the working muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Regulation of stroke volume during submaximal and maximal upright exercise in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Stroke volume increases by similar mechanisms during upright exercise in normal men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Ventilation and haemodynamics in heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Respiratory muscle function and dyspnea in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Detection of skeletal muscle fatigue in patients with heart failure using electromyography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Contrasting cardiovascular and respiratory responses to exercise in mitral valve and chronic obstructive pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Methacholine bronchial reactivity testing in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

EFFECT OF EXERCISE ON CARDIAC OUTPUT AND PULMONARY ARTERIAL PRESSURE IN NORMAL PERSONS AND IN PATIENTS WITH CARDIOVASCULAR DISEASE AND PULMONARY EMPHYSEMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Characterization of the Circulatory Response to Maximal Upright Exercise in Normal Subjects and Patients with Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Left ventricular performance during muscular exercise in patients with and without cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Maximal oxygen intake as an objective measure of cardio-respiratory performance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Maximal oxygen uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Cardiopulmonary exercise testing for evaluation of chronic cardiac failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Central hemodynamic response to exercise in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Normal and abnormal heart rate responses to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Left ventricular volume and ejection fraction response to exercise in chronic congestive heart failure: difference between dilated cardiomyopathy and previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Intact systolic left ventricular function in clinical congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Hypertensive hypertrophic cardiomyopathy of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Muscle respiratory capacity and fiber type as determinants of the lactate threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Alterations in vasomotor tone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dynamic regulation of leg vasomotor tone in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise intolerance in heart failure. Importance of skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Abnormalities of skeletal muscle in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Alterations of skeletal muscle in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle strength and endurance in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle size: relationship to muscle function in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Functional and structural adaptations in skeletal muscle of trained athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Disuse atrophy of human skeletal muscle. An enzyme histochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Operation Everest II: adaptations in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Chronic changes in skeletal muscle histology and function in peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of dichloroacetate on the exercise performance of patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effects of physical training in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Long-term effects of physical training on coronary patients with impaired ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise training as therapy for chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Randomized 4-week exercise program in patients with impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Skeletal muscle response to exercise training in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

Six minute walking test for assessing exercise capacity in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2805%2980011-8

7 January 2021

10.1016/S0033-0620(05)80011-8

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7631018